TreeWAS – Variant ID: rs10132760

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T42.4 Benzodiazepines	0.099	0.901	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.096	0.904	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.094	0.906	0.000
T42.3 Barbiturates	0.082	0.918	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.075	0.925	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.073	0.927	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.069	0.931	0.000
T42.2 Succinimides and oxazolidinediones	0.069	0.931	0.000
T42.0 Hydantoin derivatives	0.067	0.933	0.000
T42.1 Iminostilbenes	0.064	0.936	0.000
K31.9 Disease of stomach and duodenum, unspecified	0.056	0.944	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.051	0.949	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.049	0.951	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.048	0.952	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.047	0.953	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.046	0.953	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.041	0.959	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.041	0.959	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.037	0.963	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.037	0.963	0.000
T39.4 Antirheumatics, not elsewhere classified	0.035	0.965	0.000
T39.2 Pyrazolone derivatives	0.035	0.965	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.035	0.965	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.035	0.965	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.034	0.966	0.000
T50.7 Analeptics and opioid receptor antagonists	0.033	0.966	0.000
T50.5 Appetite depressants	0.033	0.966	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.033	0.966	0.000
T50.1 Loop [high-ceiling] diuretics	0.033	0.966	0.000
T50.0 Mineralocorticoids and their antagonists	0.033	0.966	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.033	0.966	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.033	0.967	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.033	0.967	0.000
T50.4 Drugs affecting uric acid metabolism	0.032	0.968	0.000
T36 Poisoning by systemic antibiotics	0.031	0.969	0.000
T50.8 Diagnostic agents	0.031	0.969	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.029	0.971	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.028	0.971	0.000
T47.4 Other laxatives	0.028	0.972	0.000
T38.1 Thyroid hormones and substitutes	0.027	0.972	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.027	0.973	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.027	0.973	0.000
T47.7 Emetics	0.027	0.973	0.000
T47.6 Antidiarrhoeal drugs	0.027	0.973	0.000
T47.5 Digestants	0.027	0.973	0.000
T47.3 Saline and osmotic laxatives	0.027	0.973	0.000
T47.2 Stimulant laxatives	0.027	0.973	0.000
T47.0 Histamine H(2)-receptor antagonists	0.027	0.973	0.000
T39.0 Salicylates	0.027	0.973	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.026	0.973	0.000
T48.5 Anti-common-cold drugs	0.026	0.973	0.000
T48.4 Expectorants	0.026	0.973	0.000
T48.3 Antitussives	0.026	0.973	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.026	0.973	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.026	0.973	0.000
T48.0 Oxytocic drugs	0.026	0.973	0.000
S00.8 Superficial injury of other parts of head	0.000	0.974	0.026
T41.5 Therapeutic gases	0.025	0.975	0.000
T41.4 Anaesthetic, unspecified	0.025	0.975	0.000
T41.3 Local anaesthetics	0.025	0.975	0.000
T41.2 Other and unspecified general anaesthetics	0.025	0.975	0.000
T41.1 Intravenous anaesthetics	0.025	0.975	0.000
T41.0 Inhaled anaesthetics	0.025	0.975	0.000
T49.9 Topical agent, unspecified	0.025	0.975	0.000
T49.8 Other topical agents	0.025	0.975	0.000
T49.7 Dental drugs, topically applied	0.025	0.975	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.025	0.975	0.000
T49.5 Ophthalmological drugs and preparations	0.025	0.975	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.025	0.975	0.000
T49.3 Emollients, demulcents and protectants	0.025	0.975	0.000
T49.2 Local astringents and local detergents	0.025	0.975	0.000
T49.1 Antipruritics	0.025	0.975	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.025	0.975	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.025	0.975	0.000
T38.9 Other and unspecified hormone antagonists	0.024	0.975	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.024	0.975	0.000
T38.7 Androgens and anabolic congeners	0.024	0.975	0.000
T38.5 Other oestrogens and progestogens	0.024	0.975	0.000
T38.4 Oral contraceptives	0.024	0.975	0.000
T38.2 Antithyroid drugs	0.024	0.975	0.000
T38.0 Glucocorticoids and synthetic analogues	0.024	0.975	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.024	0.976	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.023	0.976	0.000
T37.5 Antiviral drugs	0.023	0.976	0.000
T37.4 Anthelminthics	0.023	0.976	0.000
T37.3 Other antiprotozoal drugs	0.023	0.976	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.023	0.976	0.000
T37.1 Antimycobacterial drugs	0.023	0.976	0.000
T37.0 Sulphonamides	0.023	0.976	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.023	0.977	0.000
T36.9 Systemic antibiotic, unspecified	0.022	0.977	0.000
T36.8 Other systemic antibiotics	0.022	0.977	0.000
T36.7 Antifungal antibiotics, systemically used	0.022	0.977	0.000
T36.6 Rifamycins	0.022	0.977	0.000
T36.5 Aminoglycosides	0.022	0.977	0.000
T36.4 Tetracyclines	0.022	0.977	0.000
T36.3 Macrolides	0.022	0.977	0.000
T36.2 Chloramphenicol group	0.022	0.977	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.022	0.977	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.021	0.978	0.000
T39.1 4-Aminophenol derivatives	0.021	0.979	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.020	0.980	0.000
T36.0 Penicillins	0.018	0.981	0.000
S00 Superficial injury of head	0.000	0.981	0.019
B37.0 Candidal stomatitis	0.000	0.981	0.019
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.018	0.982	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.982	0.018
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.018	0.982	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.017	0.982	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.017	0.982	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.017	0.982	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.017	0.982	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.017	0.982	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.017	0.982	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.017	0.982	0.000
T44.0 Anticholinesterase agents	0.017	0.982	0.000
S00.5 Superficial injury of lip and oral cavity	0.000	0.983	0.017
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.983	0.017
S00.1 Contusion of eyelid and periocular area	0.000	0.983	0.017
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.017	0.983	0.000
T40.8 Lysergide [LSD]	0.017	0.983	0.000
T40.7 Cannabis (derivatives)	0.017	0.983	0.000
T40.5 Cocaine	0.017	0.983	0.000
T40.3 Methadone	0.017	0.983	0.000
T40.1 Heroin	0.017	0.983	0.000
T40.0 Opium	0.017	0.983	0.000
T40.2 Other opioids	0.017	0.983	0.000
S00.0 Superficial injury of scalp	0.000	0.984	0.016
T46 Poisoning by agents primarily affecting the cardiovascular system	0.015	0.984	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.984	0.016
T43.2 Other and unspecified antidepressants	0.015	0.985	0.000
T45.0 Antiallergic and antiemetic drugs	0.015	0.985	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.014	0.985	0.000
T45.8 Other primarily systemic and haematological agents	0.014	0.985	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.014	0.985	0.000
T45.6 Fibrinolysis-affecting drugs	0.014	0.985	0.000
T45.4 Iron and its compounds	0.014	0.985	0.000
T45.3 Enzymes, not elsewhere classified	0.014	0.985	0.000
S00.7 Multiple superficial injuries of head	0.000	0.986	0.014
S00.2 Other superficial injuries of eyelid and periocular area	0.000	0.986	0.014
T45.1 Antineoplastic and immunosuppressive drugs	0.014	0.986	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.013	0.986	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.013	0.987	0.000
T43.9 Psychotropic drug, unspecified	0.013	0.987	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.013	0.987	0.000
T40.4 Other synthetic narcotics	0.013	0.987	0.000
T40.6 Other and unspecified narcotics	0.012	0.988	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.012	0.988	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.011	0.988	0.000
S00.4 Superficial injury of ear	0.000	0.988	0.012
T46.5 Other antihypertensive drugs, not elsewhere classified	0.011	0.988	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.011	0.988	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.011	0.988	0.000
T46.7 Peripheral vasodilators	0.011	0.988	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.011	0.988	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.011	0.988	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.988	0.011
C85.0 Lymphosarcoma	0.000	0.988	0.011
T45.2 Vitamins, not elsewhere classified	0.011	0.989	0.001
M07.39 Other psoriatic arthropathies (Site unspecified)	0.011	0.989	0.000
T43.6 Psychostimulants with abuse potential	0.011	0.989	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.989	0.010
M07.3 Other psoriatic arthropathies	0.011	0.989	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.010	0.990	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.010	0.990	0.000
S00.3 Superficial injury of nose	0.000	0.990	0.010
T43.0 Tricyclic and tetracyclic antidepressants	0.010	0.990	0.000
K31 Other diseases of stomach and duodenum	0.010	0.990	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.010	0.990	0.000
T46.1 Calcium-channel blockers	0.009	0.990	0.000
T45.5 Anticoagulants	0.009	0.991	0.001
G93.0 Cerebral cysts	0.000	0.991	0.009
G93.3 Postviral fatigue syndrome	0.000	0.991	0.009
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.008	0.992	0.000
K31.4 Gastric diverticulum	0.008	0.992	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.008	0.992	0.000
K31.2 Hourglass stricture and stenosis of stomach	0.008	0.992	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.008	0.992	0.000
K31.3 Pylorospasm, not elsewhere classified	0.008	0.992	0.000
K31.1 Adult hypertrophic pyloric stenosis	0.008	0.992	0.000
G93 Other disorders of brain	0.000	0.992	0.008
M07.38 Other psoriatic arthropathies (Other)	0.008	0.992	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.008	0.992	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.008	0.992	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.008	0.992	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.008	0.992	0.000
K31.6 Fistula of stomach and duodenum	0.008	0.992	0.000
G93.2 Benign intracranial hypertension	0.000	0.992	0.008
K31.0 Acute dilatation of stomach	0.007	0.992	0.000
I45.9 Conduction disorder, unspecified	0.000	0.992	0.008
K31.8 Other specified diseases of stomach and duodenum	0.008	0.992	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.007	0.992	0.001
S00.9 Superficial injury of head, part unspecified	0.000	0.993	0.007
G93.5 Compression of brain	0.000	0.993	0.007
K70.9 Alcoholic liver disease, unspecified	0.000	0.993	0.007
T46.4 Angiotensin-converting-enzyme inhibitors	0.006	0.993	0.001
I45.5 Other specified heart block	0.000	0.993	0.007
G93.9 Disorder of brain, unspecified	0.000	0.994	0.006
G93.7 Reye's syndrome	0.000	0.994	0.006
T85.4 Mechanical complication of breast prosthesis and implant	0.006	0.994	0.000
I45.3 Trifascicular block	0.000	0.994	0.006
S42.00 Fracture of clavicle (closed)	0.006	0.994	0.000
L40.5 Arthropathic psoriasis	0.006	0.994	0.000
M54.36 Sciatica (Lumbar region)	0.000	0.994	0.006
K11.2 Sialoadenitis	0.000	0.994	0.006
I45 Other conduction disorders	0.000	0.994	0.006
G93.4 Encephalopathy, unspecified	0.000	0.995	0.005
G93.6 Cerebral oedema	0.000	0.995	0.005
Q61.3 Polycystic kidney, unspecified	0.000	0.995	0.005
G44.0 Cluster headache syndrome	0.005	0.995	0.000
Q61.0 Congenital single renal cyst	0.000	0.995	0.005
M07 Psoriatic and enteropathic arthropathies	0.005	0.995	0.000
Q61 Cystic kidney disease	0.000	0.995	0.004
K70 Alcoholic liver disease	0.000	0.996	0.004
I45.4 Nonspecific intraventricular block	0.000	0.996	0.004
K70.4 Alcoholic hepatic failure	0.000	0.996	0.004
J39.2 Other diseases of pharynx	0.000	0.996	0.004
K70.3 Alcoholic cirrhosis of liver	0.000	0.996	0.004
I45.6 Preexcitation syndrome	0.000	0.996	0.004
C09.9 Tonsil, unspecified	0.000	0.996	0.004
Q61.2 Polycystic kidney, adult type	0.000	0.996	0.004
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.996	0.004
I45.2 Bifascicular block	0.000	0.996	0.004
I45.0 Right fascicular block	0.000	0.996	0.004
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.996	0.004
Q61.9 Cystic kidney disease, unspecified	0.000	0.996	0.004
I45.8 Other specified conduction disorders	0.000	0.996	0.004
M07.6 Other enteropathic arthropathies	0.004	0.996	0.000
M07.5 Arthropathy in ulcerative colitis	0.004	0.996	0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.004	0.996	0.000
M07.2 Psoriatic spondylitis	0.004	0.996	0.000
M07.1 Arthritis mutilans	0.004	0.996	0.000
M07.0 Distal interphalangeal psoriatic arthropathy	0.004	0.996	0.000
G93.8 Other specified disorders of brain	0.000	0.996	0.004
C67.2 Lateral wall of bladder	0.004	0.996	0.000
Q61.8 Other cystic kidney diseases	0.000	0.996	0.003
Q61.1 Polycystic kidney, infantile type	0.000	0.996	0.003
K31.5 Obstruction of duodenum	0.003	0.997	0.000
Q61.4 Renal dysplasia	0.000	0.997	0.003
S19.9 Unspecified injury of neck	0.003	0.997	0.000
N13.4 Hydroureter	0.003	0.997	0.000
Q61.5 Medullary cystic kidney	0.000	0.997	0.003
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.997	0.003
I72.3 Aneurysm of iliac artery	0.000	0.997	0.003
R68.0 Hypothermia, not associated with low environmental temperature	0.000	0.997	0.003
S42.0 Fracture of clavicle	0.003	0.997	0.000
K70.0 Alcoholic fatty liver	0.000	0.997	0.003
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)	0.003	0.997	0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other	0.003	0.997	0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)	0.003	0.997	0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg	0.003	0.997	0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh	0.003	0.997	0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)	0.003	0.997	0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm	0.003	0.997	0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm	0.003	0.997	0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region	0.003	0.997	0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)	0.003	0.997	0.000
M07.19 Arthritis mutilans (Site unspecified)	0.003	0.997	0.000
M07.18 Arthritis mutilans (Other)	0.003	0.997	0.000
M07.17 Arthritis mutilans (Ankle and foot)	0.003	0.997	0.000
M07.16 Arthritis mutilans (Lower leg)	0.003	0.997	0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)	0.003	0.997	0.000
M07.14 Arthritis mutilans (Hand)	0.003	0.997	0.000
M07.13 Arthritis mutilans (Forearm)	0.003	0.997	0.000
M07.12 Arthritis mutilans (Upper arm)	0.003	0.997	0.000
M07.11 Arthritis mutilans (Shoulder region)	0.003	0.997	0.000
M07.10 Arthritis mutilans (Multiple sites)	0.003	0.997	0.000
M07.29 Psoriatic spondylitis (Site unspecified)	0.003	0.997	0.000
M07.28 Psoriatic spondylitis (Other)	0.003	0.997	0.000
M07.27 Psoriatic spondylitis (Ankle and foot)	0.003	0.997	0.000
M07.26 Psoriatic spondylitis (Lower leg)	0.003	0.997	0.000
M07.25 Psoriatic spondylitis (Pelvic region and thigh)	0.003	0.997	0.000
M07.24 Psoriatic spondylitis (Hand)	0.003	0.997	0.000
M07.23 Psoriatic spondylitis (Forearm)	0.003	0.997	0.000
M07.22 Psoriatic spondylitis (Upper arm)	0.003	0.997	0.000
M07.21 Psoriatic spondylitis (Shoulder region)	0.003	0.997	0.000
M07.20 Psoriatic spondylitis (Multiple sites)	0.003	0.997	0.000
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)	0.003	0.997	0.000
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)	0.003	0.997	0.000
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)	0.003	0.997	0.000
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)	0.003	0.997	0.000
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)	0.003	0.997	0.000
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)	0.003	0.997	0.000
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)	0.003	0.997	0.000
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)	0.003	0.997	0.000
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)	0.003	0.997	0.000
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)	0.003	0.997	0.000
M07.59 Arthropathy in ulcerative colitis (Site unspecified)	0.003	0.997	0.000
M07.58 Arthropathy in ulcerative colitis (Other)	0.003	0.997	0.000
M07.57 Arthropathy in ulcerative colitis (Ankle and foot)	0.003	0.997	0.000
M07.56 Arthropathy in ulcerative colitis (Lower leg)	0.003	0.997	0.000
M07.55 Arthropathy in ulcerative colitis (Pelvic region and thigh)	0.003	0.997	0.000
M07.54 Arthropathy in ulcerative colitis (Hand)	0.003	0.997	0.000
M07.53 Arthropathy in ulcerative colitis (Forearm)	0.003	0.997	0.000
M07.52 Arthropathy in ulcerative colitis (Upper arm)	0.003	0.997	0.000
M07.51 Arthropathy in ulcerative colitis (Shoulder region)	0.003	0.997	0.000
M07.50 Arthropathy in ulcerative colitis (Multiple sites)	0.003	0.997	0.000
M07.69 Other enteropathic arthropathies (Site unspecified)	0.003	0.997	0.000
M07.68 Other enteropathic arthropathies (Other)	0.003	0.997	0.000
M07.67 Other enteropathic arthropathies (Ankle and foot)	0.003	0.997	0.000
M07.66 Other enteropathic arthropathies (Lower leg)	0.003	0.997	0.000
M07.65 Other enteropathic arthropathies (Pelvic region and thigh)	0.003	0.997	0.000
M07.64 Other enteropathic arthropathies (Hand)	0.003	0.997	0.000
M07.63 Other enteropathic arthropathies (Forearm)	0.003	0.997	0.000
M07.62 Other enteropathic arthropathies (Upper arm)	0.003	0.997	0.000
M07.61 Other enteropathic arthropathies (Shoulder region)	0.003	0.997	0.000
M07.60 Other enteropathic arthropathies (Multiple sites)	0.003	0.997	0.000
G44.8 Other specified headache syndromes	0.003	0.997	0.000
W18.5 Trade and service area	0.003	0.997	0.000
M54.39 Sciatica (Site unspecified)	0.000	0.997	0.003
O42.9 Premature rupture of membranes, unspecified	0.000	0.997	0.003
Z03.9 Observation for suspected disease or condition, unspecified	0.000	0.997	0.003
C16.9 Stomach, unspecified	0.000	0.997	0.003
M54.3 Sciatica	0.000	0.997	0.003
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.003	0.997	0.000
Z45.8 Adjustment and management of other implanted devices	0.003	0.997	0.000
G44 Other headache syndromes	0.002	0.997	0.000
Y60.0 During surgical operation	0.002	0.998	0.000
N88.2 Stricture and stenosis of cervix uteri	0.000	0.998	0.002
Z50.8 Care involving use of rehabilitation procedures	0.000	0.998	0.002
S42.01 Fracture of clavicle (open)	0.002	0.998	0.000
G54.0 Brachial plexus disorders	0.002	0.998	0.000
K55.0 Acute vascular disorders of intestine	0.000	0.998	0.002
M90.78 Fracture of bone in neoplastic disease (Other)	0.000	0.998	0.002
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.998	0.002
N48.6 Balanitis xerotica obliterans	0.000	0.998	0.002
H74.4 Polyp of middle ear	0.000	0.998	0.002
C16.2 Body of stomach	0.000	0.998	0.002
K38.8 Other specified diseases of appendix	0.000	0.998	0.002
H25.9 Senile cataract, unspecified	0.000	0.998	0.002
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.000	0.998	0.002
T86.0 Bone-marrow transplant rejection	0.002	0.998	0.000
M54.35 Sciatica (Thoracolumbar region)	0.000	0.998	0.002
M54.34 Sciatica-Thoracic	0.000	0.998	0.002
M54.33 Sciatica-Cervicothoracic	0.000	0.998	0.002
M54.32 Sciatica-Cervical	0.000	0.998	0.002
M54.31 Sciatica-Occipit-atl-axl	0.000	0.998	0.002
M54.30 Sciatica (Multiple sites in spine)	0.000	0.998	0.002
I15.1 Hypertension secondary to other renal disorders	0.002	0.998	0.000
G44.1 Vascular headache, not elsewhere classified	0.002	0.998	0.000
S19 Other and unspecified injuries of neck	0.002	0.998	0.000
F03 Unspecified dementia	0.000	0.998	0.002
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.000	0.998	0.002
Z11.5 Special screening examination for other viral diseases	0.002	0.998	0.000
M47.92 Spondylosis, unspecified (Cervical region)	0.002	0.998	0.000
C16.5 Lesser curvature of stomach, unspecified	0.000	0.998	0.002
K70.1 Alcoholic hepatitis	0.000	0.998	0.002
O86.4 Pyrexia of unknown origin following delivery	0.002	0.998	0.000
O86.0 Infection of obstetric surgical wound	0.002	0.998	0.000
Q43.0 Meckel's diverticulum	0.002	0.998	0.000
S19.8 Other specified injuries of neck	0.002	0.998	0.000
R45.1 Restlessness and agitation	0.000	0.998	0.002
G44.3 Chronic posttraumatic headache	0.002	0.998	0.000
J95.8 Other postprocedural respiratory disorders	0.000	0.998	0.002
Z11.4 Special screening examination for human immunodeficiency virus [HIV]	0.002	0.998	0.000
C16 Malignant neoplasm of stomach	0.000	0.998	0.002
O86.8 Other specified puerperal infections	0.002	0.998	0.000
E83.1 Disorders of iron metabolism	0.002	0.998	0.000
G54.5 Neuralgic amyotrophy	0.002	0.998	0.000
C09 Malignant neoplasm of tonsil	0.000	0.998	0.002
K72.0 Acute and subacute hepatic failure	0.002	0.998	0.000
G54 Nerve root and plexus disorders	0.002	0.998	0.000
O86 Other puerperal infections	0.002	0.998	0.000
S19.7 Multiple injuries of neck	0.002	0.998	0.000
K11.5 Sialolithiasis	0.000	0.998	0.002
O86.1 Other infection of genital tract following delivery	0.002	0.998	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
G54.6 Phantom limb syndrome with pain	0.002	0.998	0.000
N48.2 Other inflammatory disorders of penis	0.000	0.998	0.002
E46 Unspecified protein-energy malnutrition	0.000	0.998	0.002
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.000	0.998	0.002
O72.1 Other immediate postpartum haemorrhage	0.002	0.998	0.000
C50.2 Upper-inner quadrant of breast	0.002	0.998	0.000
G41.9 Status epilepticus, unspecified	0.000	0.998	0.002
G54.9 Nerve root and plexus disorder, unspecified	0.002	0.998	0.000
R44.3 Hallucinations, unspecified	0.002	0.998	0.000
F34.1 Dysthymia	0.002	0.998	0.000
G54.8 Other nerve root and plexus disorders	0.002	0.998	0.000
R44.1 Visual hallucinations	0.002	0.998	0.000
C16.0 Cardia	0.000	0.998	0.002
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.998	0.002
G44.4 Drug-induced headache, not elsewhere classified	0.001	0.998	0.000
K11 Diseases of salivary glands	0.000	0.998	0.002
C16.8 Overlapping lesion of stomach	0.000	0.998	0.001
G54.1 Lumbosacral plexus disorders	0.002	0.998	0.000
J39 Other diseases of upper respiratory tract	0.000	0.998	0.002
G54.2 Cervical root disorders, not elsewhere classified	0.001	0.998	0.000
Z99.3 Dependence on wheelchair	0.000	0.998	0.002
C09.8 Overlapping lesion of tonsil	0.000	0.998	0.001
C09.1 Tonsillar pillar (anterior) (posterior)	0.000	0.998	0.001
C09.0 Tonsillar fossa	0.000	0.998	0.001
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.998	0.002
J39.8 Other specified diseases of upper respiratory tract	0.000	0.998	0.002
K07.6 Temporomandibular joint disorders	0.002	0.998	0.000
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
R16.1 Splenomegaly, not elsewhere classified	0.002	0.998	0.000
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.002	0.998	0.000
G54.7 Phantom limb syndrome without pain	0.001	0.998	0.000
G54.3 Thoracic root disorders, not elsewhere classified	0.001	0.998	0.000
O86.3 Other genito-urinary tract infections following delivery	0.001	0.998	0.000
D17.9 Benign lipomatous neoplasm, unspecified	0.000	0.998	0.002
N10 Acute tubulo-interstitial nephritis	0.002	0.998	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.002	0.998	0.000
G44.2 Tension-type headache	0.002	0.998	0.000
J38.2 Nodules of vocal cords	0.000	0.998	0.002
M46.46 Discitis, unspecified (Lumbar region)	0.001	0.998	0.000
C16.1 Fundus of stomach	0.000	0.998	0.001
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.998	0.001
K72.9 Hepatic failure, unspecified	0.002	0.998	0.000
H74 Other disorders of middle ear and mastoid	0.000	0.998	0.002
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.002	0.998	0.000
M54.37 Sciatica (Lumbosacral region)	0.001	0.998	0.001
C16.6 Greater curvature of stomach, unspecified	0.000	0.998	0.001
N89.9 Noninflammatory disorder of vagina, unspecified	0.001	0.998	0.000
Z11.2 Special screening examination for other bacterial diseases	0.001	0.998	0.000
E83.5 Disorders of calcium metabolism	0.001	0.999	0.000
I45.1 Other and unspecified right bundle-branch block	0.000	0.999	0.001
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.000	0.999	0.001
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.000	0.999	0.001
C16.4 Pylorus	0.000	0.999	0.001
C16.3 Pyloric antrum	0.000	0.999	0.001
J95.9 Postprocedural respiratory disorder, unspecified	0.000	0.999	0.001
O86.2 Urinary tract infection following delivery	0.001	0.999	0.000
Y60.5 During heart catheterisation	0.001	0.999	0.000
Z11.8 Special screening examination for other infectious and parasitic diseases	0.001	0.999	0.000
Z11 Special screening examination for infectious and parasitic diseases	0.001	0.999	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.000	0.999	0.001
K11.4 Fistula of salivary gland	0.000	0.999	0.001
K11.0 Atrophy of salivary gland	0.000	0.999	0.001
R45.2 Unhappiness	0.000	0.999	0.001
F60.3 Emotionally unstable personality disorder	0.001	0.999	0.000
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.000	0.999	0.001
J39.1 Other abscess of pharynx	0.000	0.999	0.001
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.999	0.001
Z11.1 Special screening examination for respiratory tuberculosis	0.001	0.999	0.000
H74.1 Adhesive middle ear disease	0.000	0.999	0.001
R45.8 Other symptoms and signs involving emotional state	0.000	0.999	0.001
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.000	0.999	0.001
Y60.4 During endoscopic examination	0.001	0.999	0.000
F50.0 Anorexia nervosa	0.001	0.999	0.000
L40.8 Other psoriasis	0.001	0.999	0.000
Y60.9 During unspecified surgical and medical care	0.001	0.999	0.000
Y60.7 During administration of enema	0.001	0.999	0.000
Y60.6 During aspiration, puncture and other catheterisation	0.001	0.999	0.000
Y60.3 During injection or immunisation	0.001	0.999	0.000
Y60.2 During kidney dialysis or other perfusion	0.001	0.999	0.000
Y60.1 During infusion or transfusion	0.001	0.999	0.000
I38 Endocarditis, valve unspecified	0.001	0.999	0.000
L40 Psoriasis	0.001	0.999	0.000
R68 Other general symptoms and signs	0.000	0.999	0.001
K11.9 Disease of salivary gland, unspecified	0.000	0.999	0.001
Z71.3 Dietary counselling and surveillance	0.000	0.999	0.001
Q24.8 Other specified congenital malformations of heart	0.001	0.999	0.000
M67.43 Ganglion, wrist	0.000	0.999	0.001
D37.4 Colon	0.000	0.999	0.001
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.999	0.001
J39.0 Retropharyngeal and parapharyngeal abscess	0.000	0.999	0.001
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.000	0.999	0.001
R01.0 Benign and innocent cardiac murmurs	0.000	0.999	0.001
Z11.6 Special screening examination for other protozoal diseases and helminthiases	0.001	0.999	0.000
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission	0.001	0.999	0.000
D26.1 Corpus uteri	0.000	0.999	0.001
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.001	0.999	0.000
K11.7 Disturbances of salivary secretion	0.000	0.999	0.001
K11.3 Abscess of salivary gland	0.000	0.999	0.001
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.001	0.999	0.000
L40.1 Generalised pustular psoriasis	0.001	0.999	0.000
L73.9 Follicular disorder, unspecified	0.000	0.999	0.001
X51.9 Unspecified place	0.001	0.999	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.000	0.999	0.001
K11.6 Mucocele of salivary gland	0.000	0.999	0.001
L40.4 Guttate psoriasis	0.001	0.999	0.000
L40.2 Acrodermatitis continua	0.001	0.999	0.000
R68.2 Dry mouth, unspecified	0.000	0.999	0.001
D37.9 Digestive organ, unspecified	0.000	0.999	0.001
G54.4 Lumbosacral root disorders, not elsewhere classified	0.001	0.999	0.000
H74.0 Tympanosclerosis	0.000	0.999	0.001
L40.3 Pustulosis palmaris et plantaris	0.001	0.999	0.000
N85.4 Malposition of uterus	0.001	0.999	0.000
R68.8 Other specified general symptoms and signs	0.000	0.999	0.001
R68.1 Nonspecific symptoms peculiar to infancy	0.000	0.999	0.001
T79.7 Traumatic subcutaneous emphysema	0.001	0.999	0.000
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.001	0.999	0.000
Y60.8 During other surgical and medical care	0.001	0.999	0.000
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.001	0.999	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.001	0.999	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.999	0.001
K72 Hepatic failure, not elsewhere classified	0.001	0.999	0.000
R45 Symptoms and signs involving emotional state	0.000	0.999	0.001
M79.54 Residual foreign body in soft tissue (Hand)	0.000	0.999	0.001
S02.60 Fracture of mandible (closed)	0.001	0.999	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.999	0.001
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.999	0.001
J99.8 Respiratory disorders in other diseases classified elsewhere	0.000	0.999	0.001
J99.0 Rheumatoid lung disease	0.000	0.999	0.001
K11.1 Hypertrophy of salivary gland	0.000	0.999	0.001
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.001	0.999	0.000
W18.1 Residential institution	0.001	0.999	0.000
M65.84 Other synovitis and tenosynovitis (Hand)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations